# Axil Brands, Inc.: Form 10-Q for the period ended Aug 31, 2024

- Company: [Axil Brands, Inc.](/companies/axil.md) (CIK 1718500)
- Form: 10-Q
- Filed: 2024-10-10
- Accepted by EDGAR: Oct 10, 2024, 12:00 ET
- Period: 2024-08-31
- Accession: 0001520138-24-000344
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1718500/000152013824000344/axil-20240831_10q.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1718500/000152013824000344/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2024-08-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2024-06-01 to 2024-08-31 | $5.9m | us-gaap:Revenues |
| Cost of revenue | 3 months, 2024-06-01 to 2024-08-31 | $1.7m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months, 2024-06-01 to 2024-08-31 | $4.2m | us-gaap:GrossProfit |
| Operating income | 3 months, 2024-06-01 to 2024-08-31 | −$140.7k | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months, 2024-06-01 to 2024-08-31 | $0 | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2024-06-01 to 2024-08-31 | −$109.8k | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2024-06-01 to 2024-08-31 | −$0.02 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2024-06-01 to 2024-08-31 | −$0.02 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2024-06-01 to 2024-08-31 | 6,172,379 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 3 months, 2024-06-01 to 2024-08-31 | $897.3k | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Cash and equivalents | at 2024-08-31 | $4.1m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2024-08-31 | $8.3m | us-gaap:AssetsCurrent |
| Total assets | at 2024-08-31 | $11.4m | us-gaap:Assets |
| Current liabilities | at 2024-08-31 | $3.1m | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2024-08-31 | $3.5m | us-gaap:Liabilities |
| Long-term debt | at 2024-08-31 | $144.3k | us-gaap:LongTermDebt |
| Shareholders' equity | at 2024-08-31 | $7.9m | us-gaap:StockholdersEquity |

## Management's discussion and analysis

As filed, 15,687 characters.

*The following Management’s Discussion and Analysis of Financial Condition and Results of Operations should be read in conjunction with, and is qualified in its entirety by, the unaudited consolidated financial statements and related notes thereto included in Item 1 in this Quarterly Report on Form 10-Q and with our audited consolidated financial statements and related notes included in our Annual Report on Form 10-K for the year ended May 31, 2024 filed with the SEC on August 15, 2024. Our Management’s Discussion and Analysis of Financial Condition and Results of Operations contains not only statements that are historical facts, but also statements that are forward-looking.*

*Although the forward-looking statements in this Quarterly Report on Form 10-Q reflect the good faith judgment of our management, such statements can only be based on facts and factors currently known by them. Consequently, and because forward-looking statements are inherently subject to risks and uncertainties, the actual results and outcomes may differ materially from the results and outcomes discussed in the forward-looking statements. You are urged to carefully review and consider the various disclosures made by us in herein and in our other reports as we attempt to advise interested parties of the risks and factors that may affect our business, financial condition, and results of operations and prospects. Please see “Cautionary Note Regarding Forward-Looking Statements” in this Quarterly Report on Form 10-Q for additional information.*

### Overview

The Company is engaged in the manufacturing, marketing, sale and distribution of high-tech, innovative hearing and audio enhancement and protection products that provide cutting-edge solutions for people with varied applications across many industries and professional quality hair and skin care products under various trademarks and brands.

The Company has two reportable segments: hair care and skin care, and hearing enhancement and protection.

Through our hearing enhancement and protection segment, we design, innovate, engineer, manufacture, market and service specialized systems in hearing enhancement, hearing protection, wireless audio, and communication. Through our hair care and skin care segment, we manufacture, market, sell, and distribute professional quality hair and skin care products.

The Company’s overall business strategy is to establish market awareness of our products through our direct-to-consumer campaigns. The Company's strategy centers on driving growth by expanding market share within existing channels and developing new ones through both online and traditional platforms. The Company’s primary focus is optimizing its e-commerce strategies, building sales teams to meet the needs of distribution channels, and enhancing value through strategic partnerships. We believe the increase in awareness will allow the Company to increase distribution and gain customers through our distribution partners’ retail establishments, with the goal of helping us achieve growth in market share and diversify our sales channels.

### Results of Operations

Our results of operations are summarized below.

|  | Three Months Ended August 31, 2024 | August 31, 2023 |
| --- | ---: | ---: |
| Sales, net | $5,851,272 | $6,106,269 |
| Cost of sales | 1,697,624 | 1,458,703 |
| Gross profit | 4,153,648 | 4,647,566 |
| Total operating expenses | 4,294,350 | 4,473,809 |
| Income (Loss) from operations | (140,702) | 173,757 |
| Net income (loss) | $(109,805) | $154,452 |

### For the Three Months Ended August 31, 2024 Compared to the Three Months Ended August 31, 2023

Net sales for the three months ended August 31, 2024 and 2023 were $5,851,272 and $6,106,269 respectively. Net sales for the three months ended August 31, 2024 decreased by $254,997 or 4%, as compared to the three months ended August 31, 2023, due to the decrease in marketing campaign spend and strength in our distribution channels for AXIL products.

For the three months ended August 31, 2024, the overall cost of sales increased by $238,921 or 16%, as compared to the three months ended August 31, 2023, which was primarily due to the relative increase in sales of the Company’s hair and skin care products. Cost of sales as a percentage of net revenues for the three months ended August 31, 2024 was 29.0% as compared to 23.9% for the comparable period in 2023. The marginal increase in cost of sales, as a percentage of sales, was primarily attributable to an increase in transportation costs. The Company will continue to work to increase efficiencies in procurement and logistics.

Gross profit for the three months ended August 31, 2024 and 2023 was $4,153,648 and $4,647,566, respectively. Gross profit as a percentage of sales for the three months ended August 31, 2024, was 71% as compared to 76.1% for the comparable period in 2023. The decrease in the gross profit margin for the three months ended August 31, 2024 was primarily attributable to an increase in sales of lower margin products in our segments, partially offset by a decrease in discounts in our sales of AXIL products.

Operating expenses consisted of marketing and selling expenses, compensation and related taxes, professional and consulting fees, and general and administrative costs. Operating expenses decreased by $179,459 or 4% from $4,473,809 in the three months ended August 31, 2023 to $4,294,350 in the three months ended August 31, 2024. Operating expenses as a percentage of net revenues for the three months ended August 31, 2024, were 73.4% compared to 73.3% for the three months ended August 31, 2023. The decrease in operating expenses related primarily to a net decrease in advertising and marketing expenses of $537,370 relating to prior expansion of current marketing campaigns and costs attributable to new product awareness, and partially offset by a net increase of $521,074 for professional and consulting expenses which included costs to enhance existing business processes. General and administrative costs decreased by $73,822 primarily due to a decrease in costs associated with our listing on NYSE American in February 2024. This decrease was augmented by the optimization of our workforce resulting in an overall reduction of $89,341 for compensation and related taxes for the three months ended August 31, 2024 as compared to three months ended August 31, 2023.

Loss from operations for the three months ended August 31, 2024 was $140,702 compared to income of $173,757 for the three months ended August 31, 2023. The decrease in income from operations of $314,459 or (181%) was primarily related to the increase in professional and consulting fee related to our non-cash stock based compensation and expanded marketing campaign as well as the decrease in sales.

For the three months ended August 31, 2024 no provision for income taxes was recorded since the Company incurred a net loss. For the three months ended August 31, 2023, provision for income tax expense was $65,989.

As a result of the above, we reported a net loss of $109,805 and a net income of $154,452 for the three months ended August 31, 2024 and three months ended August 31, 2023, respectively.

### Liquidity and Capital Resources

We are currently engaged in product sales and development. Although we incurred a net loss in the three months ended August 31, 2024, we recognized operating income in the past fiscal year. We currently expect to earn net income during the current fiscal year ending May 31, 2025. We believe our current cash balances, coupled with anticipated cash flow from operating activities, will be sufficient to meet our working capital requirements for at least one year from the date of issuance of the accompanying unaudited consolidated financial statements. We intend to continue to control our cash expenses as a percentage of expected revenue on an annual basis and thus may use our cash balances in the short-term to invest in revenue growth. As a result of the acquisition of AXIL & Associated Brands’ assets in June 2022, we have generated and expect we will continue to generate sufficient cash for our operational needs, including any required debt payments, for at least one year from the date of issuance of the accompanying unaudited consolidated financial statements. Management is focused on growing the Company’s existing product lines and introducing new products, as well as expanding its customer base, to increase its revenues. The Company cannot give assurance that it can increase its cash balances or limit its cash consumption and thus maintain sufficient cash balances for its planned operations or future acquisitions. Future business demands may lead to cash utilization at levels greater than recently experienced. The Company cannot provide any assurance that it will be able to raise additional capital or obtain necessary financing on acceptable terms, or at all. Subject to the foregoing, management believes that the Company has sufficient capital and liquidity to fund its operations for at least one year from the date of issuance of the accompanying unaudited consolidated financial statements.

### Cash Flows

#### Operating Activities

Net cash provided by operating activities for the three months ended August 31, 2024 was $897,318, attributable to a net loss of $109,805 offset by adjustments for depreciation and amortization, bad debts and stock-based compensation that totaled $329,544. There were favorable changes in accounts payable and accrued expenses of $405,511 and prepaid expenses and other current assets of $486,958 and a change in inventory of $120,603. The increase was partially offset by an increase in accounts receivables of $108,100 and a decrease in contract liabilities and other current liabilities of $227,393.

Net cash provided by operating activities for the three months ended August 31, 2023 was $397,172, attributable to a net income of $154,452, items of adjustments to depreciation and amortization, bad debts and stock-based compensation that totaled $132,210. There were favorable changes in accounts payable and accrued expenses of $168,399, contract and current liabilities of $476,200, and prepaid expense and other current assets of $315,751. The favorable changes were partially offset by a net decrease in operating assets and liabilities of $849,840 primarily due to increases in accounts receivable and inventory.

#### Investing Activities

Net cash flows used in investing activities for the three months ended August 31, 2024 was $41,840 due to the purchase of intangibles for the Company’s business. For the three months ended August 31, 2023, net cash flows used were $50,960, attributable to the cash used in the purchase of property and equipment.

#### Financing Activities

Net cash flows provided by financing activities for the three months ended August 31, 2024 was $39,370, and were from advances made from a related party of $41,707 partially offset by a repayment of the note payable of $2,337. Net cash flows used in financing activities for the three months ended August 31, 2023 were $117,171, and were for repayment of equipment financing and note payable of $18,079, and a decrease in the amount due from a related party of $99,092.

During the three months ended August 31, 2024, the Company has various financed items and has debt outstanding in order to run the Company’s business operations.

As of August 31, 2024, we had a secured Economic Injury Disaster Loan outstanding, administered pursuant to the CARES Act in the principal amount of $144,257, with a maturity date of May 18, 2050. The Company continues to pay interest and principal on the loan.

We are dependent on our product sales to fund our operations and may require additional capital in the future, such as pursuant to the sale of additional common stock or of debt securities or entering into credit agreements or other borrowing arrangements with institutions or private individuals, to maintain operations, which may not be available on favorable terms, or at all, and could require us to sell certain assets or discontinue or curtail our operations. If the current equity and credit markets deteriorate, it may make any necessary debt or equity financing more difficult, more costly and more dilutive. Our officers and directors have made no written commitments with respect to providing a source of liquidity in the form of cash advances, loans, and/or financial guarantees. We do not have any plans to seek additional financing at this time and anticipate that our existing cash equivalents and cash provided by operations will be sufficient to meet our working capital requirements. However, if the need arises for additional cash, there can be no assurance that we will be able to raise the capital we need for our operations on favorable terms, or at all. We may not be able to obtain additional capital or generate sufficient revenues to fund our operations. Failure to secure any necessary financing in a timely manner and on favorable terms could have a material adverse effect on our growth strategy, financial performance and stock price and could require us to delay or abandon our business plans. If we are unsuccessful at raising sufficient funds, for whatever reason, to fund our operations, we may be forced to cease operations. If we fail to raise funds, we expect that we will be required to seek protection from creditors under applicable bankruptcy laws.

### Off-Balance Sheet Arrangements

As of August 31, 2024, we do not have any off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results or operations, liquidity, capital expenditures or capital resources that is material to investors.

### Critical Accounting Policies

The preparation of condensed consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires us to make a number of estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements. Such estimates and assumptions affect the reported amounts of expenses during the reporting period. On an ongoing basis, we evaluate estimates and assumptions based upon historical experience and various other factors and circumstances. We believe our estimates and assumptions are reasonable in the circumstances; however, actual results may differ from these estimates under different future conditions.

We believe that the estimates and assumptions that are most important to the portrayal of our financial condition and results of operations, in that they require the most difficult, subjective or complex judgments, form the basis for the accounting policies deemed to be most critical to us. These critical accounting policies relate to revenue recognition, impairment of intangible assets and long-lived assets, inventory, stock compensation, and evaluation of contingencies. We believe estimates and assumptions related to these critical accounting policies are appropriate under the circumstances; however, should future events or occurrences result in unanticipated consequences, there could be a material impact on our future financial condition or results of operations.

See the footnotes to our unaudited consolidated financial statements for the three months ended August 31, 2024, included with this Quarterly Report on Form 10-Q for additional discussion of our critical accounting policies and use of estimates.

## Controls and procedures

As filed, 1,633 characters.

#### Disclosure Controls and Procedures

We maintain “disclosure controls and procedures,” as such term is defined in Rules 13a-15(e) or 15d-15(e) under the Exchange Act, that are designed to ensure that information required to be disclosed in our Exchange Act reports is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management, including our Chief Executive Officer (“CEO”) and Principal Executive Officer, and Chief Financial Officer (“CFO”) and Principal Financial and Accounting Officer, as appropriate, to allow timely decisions regarding required disclosure. We conducted an evaluation, under the supervision and with the participation of our CEO and CFO, of the effectiveness of the design and operation of our disclosure controls and procedures as of August 31, 2024. Based on this evaluation of disclosure controls and procedures as of August 31, 2024, our CEO and CFO concluded that our disclosure controls and procedures were effective.

#### Changes in Internal Control over Financial Reporting

The Company has hired additional accounting personnel and has sufficient controls over segregation of duties. Other than the forgoing, there has been no change in our internal control over financial reporting identified in connection with the evaluation required by Rules 13a-15(d) or 15d-15(d) under the Exchange Act that occurred during the fiscal quarter ended August 31, 2024 that has materially affected or is reasonably likely to materially affect our internal control over financial reporting.

Filed Oct 10, 2024.
Source: SEC EDGAR, the filing index for accession 0001520138-24-000344. Last ingested by Listed: Oct 24, 2026, 15:15 ET. No prices; not investment advice.
